Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$15,656,741
-$2,481,927 QoQ
Shares Held
61,648
-16.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#868
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $456,999,043 across 8 Drug Manufacturers - General names. JNJ ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,357,537 | $171,511,224 | |
| 2 | ABBV |
AbbVie Inc.
|
510,735 | $128,521,355 | |
| 3 | PFE |
Pfizer Inc
|
2,627,160 | $63,262,012 | |
| 4 | LLY |
ELI LILLY & Co
|
29,495 | $35,377,190 | |
| 5 | BIIB |
Biogen Inc.
|
160,057 | $34,581,915 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
61,648 | $15,656,741 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
132,573 | $7,638,856 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,500 | $449,750 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,656,741 | 61,648 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $18,138,668 | 74,205 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $166,378,693 | 803,956 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $24,498,061 | 132,122 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $107,168,941 | 701,597 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,373,699 | 92,702 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $20,883,416 | 144,402 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $221,698 | 1,368 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $249,202 | 1,705 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $718,182 | 4,540 | Shares | Defined | 2024-05-10 | |
| 2023-06-30 | $9,069,833 | 54,796 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $7,413,805 | 47,831 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $11,139,902 | 63,062 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $10,676,392 | 65,355 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $9,429,686 | 53,122 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $9,112,456 | 51,416 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $9,577,182 | 55,984 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,079,238 | 80,986 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $10,274,504 | 62,368 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $17,029,289 | 103,616 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $20,188,076 | 128,276 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $20,872,975 | 140,200 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $3,619,534 | 25,738 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $7,746,504 | 59,075 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||